Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F97Q2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,299
Award facts
- Contract value 100% obligated
- $10,299.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,299.18 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick, a pharmaceutical product used in the treatment of autoimmune conditions. This non-competitive delivery order, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, represents a firm fixed-price transaction under the company's broader pharmaceutical supply agreement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and serves as a major pharmaceutical distributor for federal medical procurement.
This delivery order is executed under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a similarly significant IDC with DLA valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to support military healthcare programs globally. These contract vehicles enable the company to supply essential medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with operational flexibility and efficiency.
Quick answers
Who was awarded contract SPE2DR26F97Q2?
SPE2DR26F97Q2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F97Q2 worth?
The government has obligated $10,299 on SPE2DR26F97Q2.
Is contract SPE2DR26F97Q2 an order under another contract?
Yes. SPE2DR26F97Q2 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F97Q2 competed?
The extent of competition for SPE2DR26F97Q2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award